Pluri (PLUR) Change in Receivables (2013 - 2025)
Pluri (PLUR) posted quarterly Change in Receivables of -$125000.0 for Q4 2025, down 256.25% year-over-year from $80000.0 in Q4 2024, and down 315.52% quarter-over-quarter from $58000.0 in Q3 2025.
Pluri (PLUR) Change in Receivables (2013 - 2025) Analysis & Trends
Pluri (PLUR) has reported Change in Receivables for 5 consecutive years, with -$125000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Change in Receivables fell 256.25% year-over-year to -$125000.0; the TTM figure through Dec 2025 stood at $29000.0 (up 103.13% YoY), while the FY2025 annual figure was $202000.0, up 365.79% from the prior year.
- Change in Receivables fell to -$125000.0 in Q4 2025 per PLUR's latest filing, from $58000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $80000.0 in Q4 2024 and bottomed at -$125000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 | -125,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -125,000.00 |
| Dec 31, 2025 | -125,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Dec 31, 2024 | 80,000.00 |
| Dec 31, 2024 | 80,000.00 |
| Sep 30, 2024 | 26,000.00 |
| Sep 30, 2024 | 26,000.00 |
| Dec 31, 2015 | -281,000.00 |
| Dec 31, 2015 | -281,000.00 |
| Sep 30, 2015 | -751,000.00 |
| Sep 30, 2015 | -751,000.00 |
| Dec 31, 2014 | 517,000.00 |
| Dec 31, 2014 | 517,000.00 |
| Sep 30, 2014 | -333,000.00 |
| Sep 30, 2014 | -333,000.00 |